Asthma
COPD
Pulmonary
COPD: Page 8
Vitamin B3 shows promise as COPD treatment
A new study suggests the vitamin helps reduce lung inflammation.
December 4, 2024
Urine analysis can predict COPD flare-ups
Applying artificial intelligence to a urine test can forecast symptoms up to a week in advance.
November 25, 2024
A healthier diet can lower risk for COPD
Research suggests low-carb, low-fat diets are associated with lower mortality in COPD patients.
November 20, 2024
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
A closer look at early COPD in younger patients
Researchers aim to provide insight into how COPD progresses in people with a smoking history.
November 20, 2024
Majority of COPD, asthma patients forgo flu shots
Analysis finds about one-third of people with lung disease get vaccinated despite risks and high costs.
November 13, 2024
Focus on comorbidities, socioeconomic factors could boost COPD care
A more holistic approach could help address health equity.
November 13, 2024
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
Interstitial lung abnormality in COPD is inversely associated with comorbidity of lung cancer
A retrospective cohort examined more than 1,100 COPD patients.
November 6, 2024
Childhood neglect associated with stroke, COPD and more
Researchers find link between childhood neglect and poor adult health outcomes with possible pathways for future treatment.
November 6, 2024
Study reinforces Yupelri effectiveness in COPD treatment
The drug is the only FDA-approved, once-daily, nebulized long-acting muscarinic agonist.
October 30, 2024
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
Phase 2 study set for COPD-related sarcopenia treatment
The study will evaluate the potential of RJx-01 to maintain muscle integrity in older people with severe COPD.
October 30, 2024
MMP-12 inhibitor shows promise in phase 1 trial
The novel and selective inhibitor could treat COPD, severe asthma and more.
October 24, 2024
FDA grants investigational clearance for new COPD, asthma drug
KT-621 is set to undergo a phase 1 clinical trial immediately.
October 24, 2024
Previous Page
Page 8 of 18
Next Page
Most Popular
Fresh insight on chronic lung transplant rejection
Global burden of COPD expected to increase through 2050
Shared washrooms in care facility linked to increased risk of viral infections
New digital tools empower children in asthma care decisions
CHEST presentation examines GLP-1 use for PAH
Scientists discover key biomarker in asthma via ferroptosis pathway